Work (Copy)
Microfluidic platforms for human cell studies
microgrx.comCrawled Nov 16, 2026
Microfluidic platforms for human cell studies
Cygnus NG-10 delivered a Micro-gRx lab on a chip experiment to the International Space Station, supported by Astronaut Serena Auñón-Chancellor.
Mario Garcia Espinoza, Marketing & Media Officer
SpaceX CRS-21 was a Commercial Resupply Service mission to the International Space Station. It was slated to launch fall 2020. The mission was contracted by NASA and flown by SpaceX on Falcon 9 rocket.
The page explores human biology in extraterrestrial environments to develop medical treatments for diseases on Earth.
Lee brings engineering and management experience in fluid and mechanical aerospace systems and launch infrastructure to Micro-gRx.
Micro-gRx is led by a real life “dynamic duo” comprised of siblings Dr. Siobhan Malany and former NASA space shuttle engineer LeGrand Malany.
The following are NASA missions that have delivered Micro-gRx experiments to the International Space Station (ISS)
Orbital Edge Accelerator has chosen eight startups for its 2026 program. The selected companies will participate in a structured accelerator initiative focused on growth and innovation. Details about the specific startups or program features are not disclosed in the announcement.
AdventHealth Translational Research Institute’s Paul M. Coen, PhD, leads a study with the University of Florida and Micro-gRX to investigate muscle cell degradation in microgravity using a lab-on-chip model on the ISS. The team finds that intermittent electrical stimulation may mitigate gene expression linked to muscle tissue breakdown. The research aims to develop countermeasures for astronauts’ muscle health during space missions.
Micro-gRx partners with Ronawk and the University of Florida to develop an experiment testing **in-space 3D cell culture techniques** aboard the **International Space Station**. The collaboration aims to advance **tissue engineering** by studying how microgravity conditions affect cellular growth and behavior. This research could inform future biomedical applications in space and on Earth.
The ISS National Lab awards **$1 million in grants** to teams advancing **organs-on-chips** research for space-based experiments. These microphysiological systems simulate human organ functions, enabling studies of disease, drug responses, and spaceflight effects. The challenge supports innovation in biomedical research using the International Space Station’s unique environment.

Micro-gRx is a microfluidic system manufacturer serving human biology researchers on Earth and in space.